Target intelligence / Profile preview

Channelrhodopsin (ChR)

Target
ChR
Molecular classification
Retinylidene protein, Light-gated ion channel, Opsin
01

Overview

Channelrhodopsins are a subfamily of retinylidene proteins that function as light-gated ion channels. When expressed in cells, channelrhodopsins enable optical control over cellular excitability and physiological processes, making them foundational tools for optogenetics. Upon illumination, they open an ion-conducting pore across the membrane, leading to either depolarization (excitation) or hyperpolarization (inhibition) depending on the ion selectivity of the channel variant.

Other names
ChR1ChR2ACRsKCRsVChR1Channelrhodopsin-1Channelrhodopsin-2
02

Mechanism of action

Light-gated ion channel activation leading to depolarization or hyperpolarization of cells.

03

Biological functions

PhototaxisLight-gated ion conductanceNeuronal excitationNeuronal inhibition
04

Disease associations

Neurological disorders (potential therapeutic target)
05

Safety considerations

Potential off-target effectsImmunogenicity (in gene therapy approaches)PhototoxicityLong-term effects of altered neuronal activity

Beyond the preview

Go deeper on Channelrhodopsin (ChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Channelrhodopsin (ChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call